I keep noticing that people search symptoms or drug classes, when “sarcoma immunotherapy HER2 CD146” is probably more useful here.

A lot of confusion around clinical trials is really confusion about what to search. The

official title for NCT07066982 is Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T

Cells in Patients With Advanced Sarcomas, focused on advanced sarcomas. CAR-T means T cells

are engineered to recognize specific markers, which is why the target names in the title are more

than just scientific decoration. It is a good reminder that the cell type and the target can change

the entire meaning of a listing. The safest next step is to review the official ClinicalTrials.gov record

and ask a specialist whether it belongs on the shortlist.